The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

A randomized, double-blind, three-arm, parallel group, phase 1 study to assess the pharmacokinetics, safety, and tolerability of PERT-IJS following a single dose of 420 mg intravenous infusion compared to the EU- and US-marketed drug product (pertuzumab; PERT) in healthy male volunteers.

Subramanian  Loganathan

Employment - Biocon Biologics

Stock and Other Ownership Interests  - Biocon

Jelle  Klein

Employment - SGS NV Belgium

Amina  Haggag

Employment - Kaiser Health Foundation

Stock and Other Ownership Interests  - Pfizer

Research Funding - Cenexel

Travel, Accommodations, Expenses - AstraZeneca

Andrew  Shaw

Employment - Viatris

Stock and Other Ownership Interests  - Viatris

Tracey  Lawrence

Employment - Viatris

Stock and Other Ownership Interests  - Viatris

Mark  Liu

Employment - Viatris

Stock and Other Ownership Interests  - Viatris

Madhava  Rao Betha

Employment - Biocon Biologics